CAMH neuroscientists develop novel protein peptide for targeted treatment of depression

CAMH neuroscientists develop novel protein peptide for targeted treatment of depression
Neuroscientists at the Centre for Addiction and Mental Health (CAMH) have developed a protein peptide that may be a novel type of highly targeted treatment for depression with a low side-effect profile. Depression affects one in ten Canadians at some time in their lives and is a leading cause of disability worldwide.
Read more on News-Medical-Net

World AIDS Day aims to fight stigma
When Gary-David Shaw learned he was HIV-positive in 1997, he wanted to end his life. The Baltimore resident didn’t want anyone to know his status, so he thought a drug overdose would be the best way to escape. He survived the overdose but developed an addiction to crack cocaine and worked as a prostitute to support his habit. A treatment program helped him so much that he launched his own …
Read more on The Capital

Safe-injection sites to open in Que.
An addiction support group in Quebec has announced a controversial plan to open two supervised injection sites for intravenous drug users, with or without government approval.
Read more on CBC Montreal